Our partner is focused on developing therapies for rare and autoimmune diseases. Their approach targets key drivers of inflammation to address unmet medical needs, with the goal of improving patient outcomes and quality of life through innovative treatments.

This critical hire identified and attracted investors and other key partnerships for future development. They represented the company internally, to senior leadership, and externally to current and potential partners. They also helped identify unmet needs in disease states and execute market research to see where the platform enabled them to pursue other areas.